Jeffrey L. Rutherford - 05 Feb 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP and CFO
Signature
Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Issuer symbol
DBD
Transactions as of
05 Feb 2022
Net transactions value
-$36,382
Form type
4
Filing time
08 Feb 2022, 20:13:43 UTC
Previous filing
31 Jan 2022
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability $36,382 -4,410 -1.9% $8.25 227,760 05 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 68,572 05 Feb 2022 Common Shares 68,572 $4.08 Direct F3
holding DBD Non-Qualified Stock Option 18,898 05 Feb 2022 Common Shares 18,898 $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.